Skip to main content
. Author manuscript; available in PMC: 2023 Aug 5.
Published in final edited form as: Vaccine. 2022 Jun 27;40(33):4764–4771. doi: 10.1016/j.vaccine.2022.06.059

Table 2.

Serum concentrations of immunoglobulin G antibodies to pneumococcal serotypes among 126 infants with sera at birth by HIV exposure status

Serotype Median (IQR) Serum Antibody
Concentration (μg/mL)
padja
HEU Infants
(n= 35)
HUU Infants
(n= 91)
1 0.20 (0.03–0.46) 0.25 (0.03–0.53) 0.59
3 0.31 (0.17–0.49) 0.34 (0.25–0.61)
0.26 (0.12, 0.40)
0.50
4 0.22 (0.11–0.42)
0.03 (0.03, 0.23)
0.26 (0.12–0.40) 0.64
5 0.03 (0.03–0.24)
0.27 (0.21, 0.69)
0.22 (0.05–0.37) 0.046
6A 0.38 (0.28–0.78) 0.70 (0.41–1.13) 0.09
6B 0.27 (0.21–0.69)
0.19 (0.15, 0.54)
0.21 (0.21–0.64) 0.84
7F 0.25 (0.04–0.69) 0.33 (0.15–0.73) 0.06
9V 0.19 (0.15–0.54) 0.30 (0.15–0.72)
1.60 (1.13, 2.82)
0.20
14 1.60 (1.14–2.82)
0.27 (0.07, 0.60)
2.26 (1.22–4.51) 0.39
18C 0.27 (0.07–0.60)
0.79 (0.33, 2.57)
0.40 (0.16–0.91) 0.13
19A 1.46 (0.81–2.08)
0.24 (0.14, 0.83)
1.85 (1.22–3.38)
0.32 (0.14, 0.94)
0.008
19F 0.79 (0.33–2.57) 0.90 (0.33–2.23) 0.66
23F 0.25 (0.14–0.83) 0.32 (0.14–0.94) 0.27

IQR, interquartile range; μg, microgram; mL, milliliter; HEU, HIV-exposed uninfected; HUU, HIV-unexposed uninfected

a

Adjusted p values were estimated from linear regression models evaluating associations between HIV exposure status and log-transformed serum antibody concentrations and adjusted for infant birth weight and maternal age